James C.H. Hardwick

12.7k total citations · 1 hit paper
125 papers, 5.9k citations indexed

About

James C.H. Hardwick is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, James C.H. Hardwick has authored 125 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 40 papers in Molecular Biology and 30 papers in Surgery. Recurrent topics in James C.H. Hardwick's work include Genetic factors in colorectal cancer (26 papers), Colorectal Cancer Screening and Detection (22 papers) and Gastric Cancer Management and Outcomes (17 papers). James C.H. Hardwick is often cited by papers focused on Genetic factors in colorectal cancer (26 papers), Colorectal Cancer Screening and Detection (22 papers) and Gastric Cancer Management and Outcomes (17 papers). James C.H. Hardwick collaborates with scholars based in Netherlands, United States and Germany. James C.H. Hardwick's co-authors include Gijs R. van den Brink, Maikel P. Peppelenbosch, Liudmila L. Kodach, Sander J. H. van Deventer, G. Johan A. Offerhaus, Daniël W. Hommes, G. J. A. Offerhaus, Evelien Dekker, Sylvia A. Bleuming and Paul Fockens and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature Genetics.

In The Last Decade

James C.H. Hardwick

119 papers receiving 5.8k citations

Hit Papers

FBW7 mutations in leukemic cells mediate NOTCH pathway ac... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James C.H. Hardwick Netherlands 41 2.7k 2.1k 1.1k 992 915 125 5.9k
Hani Gabra United Kingdom 44 3.2k 1.2× 2.4k 1.1× 915 0.8× 696 0.7× 986 1.1× 174 7.4k
Ronald J. Weigel United States 39 2.7k 1.0× 1.6k 0.7× 1.3k 1.1× 690 0.7× 1.4k 1.6× 173 5.8k
Stefania Staibano Italy 43 2.8k 1.0× 2.4k 1.1× 915 0.8× 1.2k 1.2× 471 0.5× 229 6.5k
Tetsuji Takayama Japan 37 2.3k 0.9× 1.7k 0.8× 1.3k 1.1× 1.1k 1.1× 368 0.4× 268 6.2k
Zsolt Tulassay Hungary 42 2.1k 0.8× 1.6k 0.8× 1.8k 1.6× 847 0.9× 624 0.7× 302 5.9k
Pieter Demetter Belgium 43 1.8k 0.7× 2.5k 1.2× 1.2k 1.1× 691 0.7× 643 0.7× 199 6.4k
Hal W. Hirte Canada 45 3.2k 1.2× 3.7k 1.7× 797 0.7× 1.3k 1.3× 803 0.9× 156 8.1k
Lopa Mishra United States 49 3.8k 1.4× 2.7k 1.3× 1.4k 1.2× 819 0.8× 435 0.5× 169 7.8k
Thomas Rutherford United States 46 2.9k 1.1× 2.4k 1.1× 838 0.7× 618 0.6× 623 0.7× 195 7.9k
Robert S. Warren United States 43 3.5k 1.3× 3.9k 1.8× 1.3k 1.2× 1.1k 1.2× 847 0.9× 123 8.7k

Countries citing papers authored by James C.H. Hardwick

Since Specialization
Citations

This map shows the geographic impact of James C.H. Hardwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C.H. Hardwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C.H. Hardwick more than expected).

Fields of papers citing papers by James C.H. Hardwick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James C.H. Hardwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C.H. Hardwick. The network helps show where James C.H. Hardwick may publish in the future.

Co-authorship network of co-authors of James C.H. Hardwick

This figure shows the co-authorship network connecting the top 25 collaborators of James C.H. Hardwick. A scholar is included among the top collaborators of James C.H. Hardwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James C.H. Hardwick. James C.H. Hardwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Didden, Paul, Arjun D. Koch, Jurjen J. Boonstra, et al.. (2025). Short-term outcomes of endoscopic submucosal dissection for suspected T1 colorectal cancers: a European experience. Gastrointestinal Endoscopy. 103(1). 147–155.
2.
Kruizinga, Matthijs D., Hao Dang, Frederik E. Stuurman, et al.. (2025). Physical recovery after local resection of nonpedunculated rectal adenomas and T1 carcinomas: endoscopic submucosal dissection versus transanal minimally invasive surgery. Gastrointestinal Endoscopy. 102(4). 583–592.e6. 1 indexed citations
3.
Dang, Hao, et al.. (2023). Patient educational videos on T1 colorectal cancer. VideoGIE. 8(12). 527–528. 2 indexed citations
4.
Dang, Hao, Alexandra M. J. Langers, Denise E. Hilling, et al.. (2023). Colorectal polyps: Targets for fluorescence‐guided endoscopy to detect high‐grade dysplasia and T1 colorectal cancer. United European Gastroenterology Journal. 11(3). 282–292. 4 indexed citations
5.
Kouwen, Mariëtte van, Birgitta Versluys, Delphine Bonnet, et al.. (2022). High yield of surveillance in patients diagnosed with constitutional mismatch repair deficiency. Journal of Medical Genetics. 60(7). 679–684. 9 indexed citations
6.
Harryvan, Tom J., Arend Mulder, Peter A. van Veelen, et al.. (2022). Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S. Journal for ImmunoTherapy of Cancer. 10(3). e003591–e003591. 28 indexed citations
7.
Roelands, Jessica, Manon van der Ploeg, Marieke E. Ijsselsteijn, et al.. (2022). Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis. Gut. 72(7). 1326–1339. 47 indexed citations
8.
Schoonderwoerd, Mark J.A., Madelon Paauwe, Marieke C. Barnhoorn, et al.. (2020). Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy. Clinical Cancer Research. 26(14). 3831–3842. 37 indexed citations
9.
Paauwe, Madelon, Mark J.A. Schoonderwoerd, Roxan F.C.P. Helderman, et al.. (2018). Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis. Clinical Cancer Research. 24(24). 6331–6344. 132 indexed citations
10.
Paauwe, Madelon, Gabi W. van Pelt, Chao Cui, et al.. (2016). Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer. Oncogene. 35(31). 4069–4079. 56 indexed citations
11.
Heijmans, Jarom, Mattheus C.B. Wielenga, Sanne L. Rosekrans, et al.. (2013). Oestrogens promote tumorigenesis in a mouse model for colitis-associated cancer. Gut. 63(2). 310–316. 36 indexed citations
12.
Voorneveld, Philip W., Rutger J. Jacobs, Noel F.C.C. de Miranda, et al.. (2013). Evaluation of the prognostic value of pSMAD immunohistochemistry in colorectal cancer. European Journal of Cancer Prevention. 22(5). 420–424. 13 indexed citations
13.
Dihal, Ashwin A., Carina L. Bos, Philip W. Voorneveld, et al.. (2011). 5-aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer. Gut. 61(12). 1708–1715. 27 indexed citations
14.
Kodach, Liudmila L., Eliza Wiercinska, Noel F.C.C. de Miranda, et al.. (2008). The Bone Morphogenetic Protein Pathway Is Inactivated in the Majority of Sporadic Colorectal Cancers. EUR Research Repository (Erasmus University Rotterdam). 1 indexed citations
16.
Kodach, Liudmila L., Sylvia A. Bleuming, Maikel P. Peppelenbosch, et al.. (2007). The Effect of Statins in Colorectal Cancer Is Mediated Through the Bone Morphogenetic Protein Pathway. Gastroenterology. 133(4). 1272–1281. 63 indexed citations
17.
Saadi, Amel, Madhumita Das, Nicholas J. Clemons, et al.. (2007). A potential role for Periostin in Barrett’s carcinogenesis. Cancer Epidemiology and Prevention Biomarkers. 16.
18.
Roth, Jennifer A., Susan Korenchuk, Theresa Zhang, et al.. (2007). Mechanisms of in vitro acquired resistance to vorinostat (suberoylanilide hydroxamic acid, SAHA). Cancer Research. 67. 694–694. 3 indexed citations
19.
Kodach, Liudmila L., Carina L. Bos, Nelsón Durán, et al.. (2005). Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells. Carcinogenesis. 27(3). 508–516. 122 indexed citations
20.
Brink, Gijs R. van den, Sylvia A. Bleuming, James C.H. Hardwick, et al.. (2004). Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nature Genetics. 36(3). 277–282. 292 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026